| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 57.10× | 57.10× | 53.73× | 52.68× | 51.58× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 5.73× | 4.90× | 5.03× | 4.00× | 4.94× | ||
| 1.57× | 1.57× | 1.70× | 1.75× | 1.93× | ||
| 0.97× | 0.97× | 0.86× | 0.84× | 1.12× | ||
| 0.86× | 0.86× | 0.78× | 0.73× | 0.85× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 51.58 | 52.68 | 53.73 | 57.10 | 57.10 | |
| Working Capital Turnover | 4.94 | 4.00 | 5.03 | 4.90 | 5.73 | |
| Asset Turnover | 1.93 | 1.75 | 1.70 | 1.57 | 1.57 | |
| Cash Conversion (CFO/Net Income) | 1.12 | 0.84 | 0.86 | 0.97 | 0.97 | |
| CFO/EBITDA | 0.85 | 0.73 | 0.78 | 0.86 | 0.86 |